7827 — HanchorBio Balance Sheet
0.000.00%
- TWD22.34bn
- TWD21.73bn
- TWD312.22m
Annual balance sheet for HanchorBio, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 246 | 429 | 420 | 1,064 |
| Net Total Receivables | 1.75 | 1.7 | 3 | 4.59 |
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 251 | 440 | 433 | 1,082 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 133 | 118 | 101 | 81.6 |
| Net Intangible Assets | ||||
| Other Long Term Assets | ||||
| Total Assets | 393 | 568 | 542 | 1,172 |
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 190 | 223 | 303 | 302 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Minority Interest | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 1,228 | 1,938 | 311 | 506 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Treasury Stock | ||||
| Other Equity | ||||
| Total Equity | -835 | -1,371 | 231 | 666 |
| Total Liabilities & Shareholders' Equity | 393 | 568 | 542 | 1,172 |
| Total Common Shares Outstanding |